INEI - ANLIS Malbrán
Invasive pneumococcal disease in Argentina: a snapshot from a retrospective observational study on serotypes, antimicrobial resistance, and the potential impact of the COVID-19 pandemic (2018–2022)
Genomic characterization of plasmids of mcr-1-positive Escherichia coli isolated from cohabiting rats, dairy cattle and pigs
Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries
Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance
National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in thePost-COVID-19 Era in Argentina: The RECAPT-AR Study
Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina
Hetero-antagonism of avibactam and sulbactam with cefiderocolcefiderocol cefiderocol cefiderocol in carbapenem-resistant Acinetobacter spp.
Antimicrobial resistance occurrence in the South American Sea Lion (Otaria flavescens) from Patagonia, Argentina, from a One Health perspective
Geographical migration and fitness dynamics of Streptococcus pneumoniae
Seven?day antibiotic therapy for Enterobacterales bacteremia in high?risk neutropenic patients: toward a new paradigm
Improved Blue Carba test and Carba NP test for detection and classification of major Class A and B carbapenemases, including dual producers, among Gram-negative bacilli
Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter spp
Emergence of NDM-producingEnterobacterales infections in companionanimals from Argentina
National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework
New insights on mcr-1-harboring plasmids from human clinical Escherichia coli isolates
Beneath the surface: a case report on nonencapsulated Streptococcus pneumoniae-associated invasive disease in an immunocompromised patient
KPC-2 allelic variants in Klebsiella pneumoniae isolates resistant to ceftazidime-avibactam from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97
Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia
Different evolution of S. aureus methicillin-resistent and methicillin-susceptible infections, Argentina
Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation